Annett Maderer
Mainz, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Collagen turnover biomarkers as diagnostic, prognostic, and therapy monitoring indicators in gastric cancer.
Journal: Cancer biomarkers : section A of Disease markers
Published: August 21, 2026
EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer.
Journal: Translational oncology
Published: March 28, 2026
Collagen turnover biomarkers to predict outcome of patients with biliary cancer.
Journal: BMC gastroenterology
Published: August 15, 2024
Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials.
Journal: Frontiers in oncology
Published: June 07, 2022
CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset.
Journal: Acta oncologica (Stockholm, Sweden)
Published: August 06, 2021
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3).
Journal: International journal of cancer
Published: May 27, 2021
The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy.
Journal: Cancers
Published: March 31, 2021
Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2).
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: April 09, 2020
Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases.
Journal: Annals of surgery
Published: October 22, 2019
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 17, 2019
Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?
Journal: BMC cancer
Published: November 23, 2018
Last Updated: 09/26/2026